Lilly Evista Overstatement of Benefits Cited By FDA For A Second Time
Advertisements for Lilly's Evista overstate the benefits of the product while minimizing the possible risks, FDA declared in a Jan. 12 letter to the company.
Advertisements for Lilly's Evista overstate the benefits of the product while minimizing the possible risks, FDA declared in a Jan. 12 letter to the company.